Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2011

Open Access 01-12-2011 | Case report

Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report

Authors: Stephan Braun, Daniel Reimer, Isolde Strobl, Ulrike Wieland, Petra Wiesbauer, Elisabeth Müller-Holzner, Siegfried Fessler, Arthur Scherer, Christian Marth, Alain G Zeimet

Published in: Journal of Medical Case Reports | Issue 1/2011

Login to get access

Abstract

Introduction

Well-documented cases of untreated cervical intra-epithelial dysplasia resulting in fatal progression of invasive cervical cancer are scarce because of a long pre-invasive state, the availability of cervical cytology screening programs, and the efficacy of the treatment of both pre-invasive and early-stage invasive lesions.

Case presentation

We present a well-documented case of a 29-year-old Caucasian woman who was found, through routine conventional cervical cytology screening, to have pathologic Papanicolaou (Pap) grade III D lesions (squamous cell abnormalities). She subsequently died as a result of human papillomavirus type 18-associated cervical cancer after she refused all recommended curative therapeutic procedures over a period of 13 years.

Conclusion

This case clearly demonstrates a caveat against the promotion and use of complementary alternative medicine as pseudo-immunologic approaches outside evidence-based medicine paths. It also demonstrates the impact of the individualized demands in diagnosis, treatment and palliative care of patients with advanced cancer express their will to refuse evidence-based treatment recommendations.
Appendix
Available only for authorised users
Literature
1.
go back to reference FUTURE II Study Group: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007, 356: 1915-1927.CrossRef FUTURE II Study Group: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007, 356: 1915-1927.CrossRef
2.
go back to reference Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL, Canadian Cervical Cancer Screening Trial Study Group: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007, 357: 1579-1588. 10.1056/NEJMoa071430.CrossRefPubMed Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL, Canadian Cervical Cancer Screening Trial Study Group: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007, 357: 1579-1588. 10.1056/NEJMoa071430.CrossRefPubMed
3.
go back to reference Runowicz CD: Molecular screening for cervical cancer: time to give up pap tests?. N Engl J Med. 2007, 357: 1650-1653. 10.1056/NEJMe078155.CrossRefPubMed Runowicz CD: Molecular screening for cervical cancer: time to give up pap tests?. N Engl J Med. 2007, 357: 1650-1653. 10.1056/NEJMe078155.CrossRefPubMed
4.
go back to reference Kreuter A, Brockmeyer NH, Hochdorfer B, Weissenborn SJ, Stücker M, Swoboda J, Altmeyer P, Pfister H, Wieland U: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol. 2005, 52: 603-608. 10.1016/j.jaad.2004.11.026.CrossRefPubMed Kreuter A, Brockmeyer NH, Hochdorfer B, Weissenborn SJ, Stücker M, Swoboda J, Altmeyer P, Pfister H, Wieland U: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol. 2005, 52: 603-608. 10.1016/j.jaad.2004.11.026.CrossRefPubMed
5.
go back to reference McCulley TJ, Yip CC, Bullock JD, Warwar RE, Hood DL: Cervical carcinoma metastatic to the orbit. Ophthal Plast Reconstr Surg. 2002, 18: 385-387. 10.1097/00002341-200209000-00013.CrossRefPubMed McCulley TJ, Yip CC, Bullock JD, Warwar RE, Hood DL: Cervical carcinoma metastatic to the orbit. Ophthal Plast Reconstr Surg. 2002, 18: 385-387. 10.1097/00002341-200209000-00013.CrossRefPubMed
6.
go back to reference Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000, 92: 464-474. 10.1093/jnci/92.6.464.CrossRefPubMed Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000, 92: 464-474. 10.1093/jnci/92.6.464.CrossRefPubMed
7.
go back to reference Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999, 180: 1415-1423. 10.1086/315086.CrossRefPubMed Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999, 180: 1415-1423. 10.1086/315086.CrossRefPubMed
8.
go back to reference Sawaya GF, Smith-McCune K: HPV vaccination: more answers, more questions. N Engl J Med. 2007, 356: 1991-1993. 10.1056/NEJMe078060.CrossRefPubMed Sawaya GF, Smith-McCune K: HPV vaccination: more answers, more questions. N Engl J Med. 2007, 356: 1991-1993. 10.1056/NEJMe078060.CrossRefPubMed
9.
go back to reference Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL: Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003, 95: 1336-1343.CrossRefPubMed Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL: Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst. 2003, 95: 1336-1343.CrossRefPubMed
10.
go back to reference Holowaty P, Miller AB, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999, 91: 252-258. 10.1093/jnci/91.3.252.CrossRefPubMed Holowaty P, Miller AB, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999, 91: 252-258. 10.1093/jnci/91.3.252.CrossRefPubMed
11.
go back to reference Janni W, Hepp F, Strobl B, Rack B, Rjosk D, Kentenich C, Schindlbeck C, Hantschmann P, Pantel K, Sommer H, Braun S: Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer. 2003, 97: 405-411. 10.1002/cncr.11066.CrossRefPubMed Janni W, Hepp F, Strobl B, Rack B, Rjosk D, Kentenich C, Schindlbeck C, Hantschmann P, Pantel K, Sommer H, Braun S: Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer. 2003, 97: 405-411. 10.1002/cncr.11066.CrossRefPubMed
Metadata
Title
Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report
Authors
Stephan Braun
Daniel Reimer
Isolde Strobl
Ulrike Wieland
Petra Wiesbauer
Elisabeth Müller-Holzner
Siegfried Fessler
Arthur Scherer
Christian Marth
Alain G Zeimet
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2011
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-5-316

Other articles of this Issue 1/2011

Journal of Medical Case Reports 1/2011 Go to the issue